Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?3.3mm NC, SLA? 12mm, Ti, Loxim: medical device reports filed with FDA

9,992 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

9,992
device reports naming the brand
0% of all MAUDE reports · about 1,463 a year
3,117
reports, 12 months to August 2026
2,632 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

9,992 medical device reports received by FDA name the brand "BLT ?3.3mm NC, SLA? 12mm, Ti, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

3,117 reports arrived in the 12 months to August 2026, up 18% from 2,632 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (92.1%), loss of osseointegration (6.7%) and fracture (0.4%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0355710Sep 2021: 60Oct 2021: 38Nov 2021: 46Dec 2021: 462022Jan 2022: 38Feb 2022: 67Mar 2022: 36Apr 2022: 53May 2022: 49Jun 2022: 51Jul 2022: 59Aug 2022: 48Sep 2022: 59Oct 2022: 73Nov 2022: 91Dec 2022: 692023Jan 2023: 47Feb 2023: 47Mar 2023: 61Apr 2023: 91May 2023: 102Jun 2023: 109Jul 2023: 148Aug 2023: 125Sep 2023: 171Oct 2023: 134Nov 2023: 171Dec 2023: 1752024Jan 2024: 151Feb 2024: 157Mar 2024: 109Apr 2024: 218May 2024: 155Jun 2024: 217Jul 2024: 183Aug 2024: 184Sep 2024: 187Oct 2024: 138Nov 2024: 210Dec 2024: 2062025Jan 2025: 188Feb 2025: 145Mar 2025: 164Apr 2025: 127May 2025: 0Jun 2025: 710Jul 2025: 222Aug 2025: 335Sep 2025: 416Oct 2025: 206Nov 2025: 311Dec 2025: 2852026Jan 2026: 259Feb 2026: 239Mar 2026: 150Apr 2026: 191May 2026: 176Jun 2026: 345Jul 2026: 293Aug 2026: 246

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01,5553,1092019: 11920192020: 20620202021: 47020212022: 69320222023: 1,38120232024: 2,11520242025: 3,10920252026: 1,8992026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%9,992
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report96.9%9,685
Voluntary report0%0
User facility report0%0
Distributor report3.1%307
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate9,20692.1%62.8%
Loss of osseointegration6666.7%22.4%
Fracturea broken bone370.4%1.6%
Difficult to insertthe device was hard to insert40%0.4%
Therapeutic or diagnostic output failure10%0%
Unintended movement10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,72517.3%
Painpain, site not specified1,10111%
Inflammationinflammation6006%
Swelling/ edema4384.4%
Hemorrhage/blood loss/bleeding2632.6%
Tissue damage1681.7%
Fistula1271.3%
Abscessa collection of pus880.9%
Numbnessnumbness530.5%
Hyperresponsive to stimuli470.5%
Hypersensitivity/allergic reaction260.3%
Failure of implant130.1%
Swellingswelling100.1%
Inadequate osseointegration90.1%
Increased sensitivity80.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?3.3mm NC, SLA? 12mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports9,9923,924,24126,136,888
Share of that pool—0.3%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer96.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?3.3mm NC, SLA? 12mm, Ti, Loxim reports

How many FDA reports name BLT ?3.3mm NC, SLA? 12mm, Ti, Loxim?

9,992 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 3,117 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (92.1%), loss of osseointegration (6.7%), fracture (0.4%), difficult to insert (0%) and therapeutic or diagnostic output failure (0%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (96.9%) and distributor reports (3.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?3.3mm NC, SLA? 12mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.